Byetta was the first FDA-approved GLP-1 drug
TCM interventions, through modulation of gut microbiota and inhibition of key enzymes like flavin-containing monooxygenase 3 (FMO3), offer promising therapeutic avenues
Supplemental carnitine may be helpful in osteoporosis.[ref] Carnitine in NAFLD and liver health: Non-alcoholic fatty liver disease (NAFLD) affects about one-third of the population in Western countries
Cardiovascular exercise supports calorie expenditure and cardiovascular health but should not replace resistance training
A travs de la configuracin de tu navegador, puedes bloquear o alertar de la presencia de este tipo de cookies, si bien dicho bloqueo afectar al correcto funcionamiento de las distintas funcionalidades de nuestra pgina web
One 2026 narrative review concluded that GLP-1 receptor agonist therapy is associated with meaningful nutritional deficiencies and that individualized nutritional assessment and lab evaluation may be appropriate, especially in people at higher risk of malnutrition
